William Ball, MD, Appointed Interim Vice President for Research
CINCINNATIWilliam Ball, MD, has been appointed interim vice president for research for the University of Cincinnati (UC) effective Aug. 1.
Ball will be responsible for the universitys research enterprise, which last year received more than $443 million in funding, placing UC No. 25 in the country among public universities for federal research expenditures. Reporting to Santa Ono, PhD, senior vice president for academic affairs and provost, the Office of Research includes all graduate and undergraduate research efforts, intellectual property, entrepreneurial affairs and technology commercialization, and sponsored research administration.
"There is tremendous respect by the university community for Dr. Ball as a scientist, clinician and administrator, Ono said. "Researchers across the university express admiration for him as a human being and for his knowledge of the entire research portfolio at UC. We are fortunate to have someone of his caliber step into this important role for the university. I am looking forward to working with him to move UC to even greater heights as a research powerhouse."
Currently a UC professor of radiology, biomedical engineering and pediatrics and former interim chair and chair of the universitys department of biomedical engineering from 2001 to 2008, Ball has extensive experience in cross-campus collaboration, Ono noted. He currently serves as attending neuroradiologist at Cincinnati Childrens Hospital Medical Center.
"I am deeply honored to be asked to fill this essential role at UC in what is now a very exciting time with respect to new direction and leadership at the university. There is no reason to believe, based on the quality of our students, faculty, and staff as well as available resources, that we cannot significantly advance our research efforts regionally, nationally and internationally, Ball said.
Ball received his medical degree from Tulane University School of Medicine and completed a fellowship in pediatric radiology/pediatric neuroradiology at Cincinnati Childrens. He completed one year of fellowship training in neuroradiology and served on their faculty at the University of New Mexico Medical Center before joining UC and Cincinnati Childrens in 1984.
While at UC, Ball has chaired or co-chaired a number of initiatives, including the Bioinformatics Taskforce, the Civic Engagement Council, the Initiatives subcommittee of the Academic Priorities Taskforce and the Research in Radiology Taskforce. He is a steering committee member for the universitys Clinical and Translational Science Award through the Center for Clinical and Translational Science and Training, and was a member of the executive committee for the College of Medicines strategic planning initiative.
Ball has conducted extensive research on pediatric neuro-imaging and has contributed to nearly 140 peer-reviewed manuscripts and 13 book chapters.
Ball replaces Sandra Degen, PhD, who announced in May that she is stepping down from the position July 1 to return to the faculty. Degen served as vice president for research since September 2004.
During her tenure, research funding for the university and its affiliates increased from $319 million to more than $443 million in fiscal year 2010. During this time, the university was awarded a $23 million Clinical and Translational Science Award from the National Institutes of Health and was the recipient of more than 130 American Recovery and Reinvestment Act awards totaling more than $57 million.
William Ball, MD, Christian R. Holmes Professor and Dean, College of Medicine, and senior vice president for health affairs
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.